The growth of the global biosimilar monoclonal antibody market is driven by increase in prevalence of chronic diseases globally, increase in the number of product approvals and increase in the number of patent expirations. PORTLAND, Ore., Sept. 18, 2023 /PRNewswire/ — Allied Market…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.